Treatment of NSCLC after chemoimmunotherapy — are we making headway?
- DOI
- 10.1038/s41571-025-01061-7
- Published
- 2025-08-14
- Container
- Nature Reviews Clinical Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41571-025-01061-7,
title = {Treatment of NSCLC after chemoimmunotherapy — are we making headway?},
author = {Martin Reck and Nikolaj Frost and Solange Peters and Bernard A. Fox and Roberto Ferrara and Rajkumar Savai and Fabrice Barlesi},
year = {2025},
journal = {Nature Reviews Clinical Oncology},
doi = {10.1038/s41571-025-01061-7},
url = {https://doi.org/10.1038/s41571-025-01061-7}
}RIS
TY - JOUR TI - Treatment of NSCLC after chemoimmunotherapy — are we making headway? AU - Martin Reck AU - Nikolaj Frost AU - Solange Peters AU - Bernard A. Fox AU - Roberto Ferrara AU - Rajkumar Savai AU - Fabrice Barlesi PY - 2025 JO - Nature Reviews Clinical Oncology DO - 10.1038/s41571-025-01061-7 UR - https://doi.org/10.1038/s41571-025-01061-7 ER -
APA
Reck, M., Frost, N., Peters, S., Fox, B. A., Ferrara, R., Savai, R., & Barlesi, F. (2025). Treatment of NSCLC after chemoimmunotherapy — are we making headway?. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-025-01061-7
Source records
- crossref · retrieved 2026-09-25T12:36:34.339Z